Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.14 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.95.
Market Cap
9.14T
Revenue
4.59T
Profits
199.03B
PE Ratio
45.95
Profit Margin
4.34%
Dividend Yield
0.39%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | -0.63% | 1,281,005 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 640.85B | -0.38% | 3,295,174 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 447.48B | -0.54% | 2,192,557 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 386.51B | 0.16% | 1,833,690 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 310.07B | -2.57% | 4,003,267 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 295.16B | -1.61% | 1,367,154 | 60.44B |
| 7 | NVS | Novartis AG | 284.61B | -1.18% | 1,386,510 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 218.12B | -0.85% | 4,809,732 | 50.57B |
| 9 | AMGN | Amgen Inc. | 198.61B | -0.03% | 1,729,319 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 189.72B | -1.18% | 522,212 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 168.63B | -0.40% | 8,452,448 | 29.74B |
| 12 | ABT | Abbott Laboratories | 166.27B | -0.40% | 2,878,855 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 148.40B | -1.94% | 877,783 | 10.58B |
| 14 | PFE | Pfizer Inc. | 138.10B | 0.66% | 18,686,786 | 63.32B |
| 15 | DHR | Danaher Corporation | 135.42B | -1.47% | 908,425 | 24.78B |
| 16 | CVS | CVS Health Corporation | 133.97B | 0.64% | 2,318,786 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 129.39B | -2.38% | 773,572 | 12.22B |
| 18 | SYK | Stryker Corporation | 125.30B | -0.33% | 894,753 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.88B | -0.42% | 3,621,584 | 48.48B |
| 20 | GSK | GSK plc | 105.41B | -0.98% | 1,908,272 | 43.29B |
| 21 | MDT | Medtronic plc | 105.25B | -1.91% | 2,216,125 | 36.36B |
| 22 | SNY | Sanofi | 103.14B | 0.19% | 1,042,696 | 54.60B |
| 23 | MCK | McKesson Corporation | 95.48B | 1.02% | 486,000 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 91.11B | 0.17% | 502,149 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 91.02B | -3.02% | 683,229 | 76.39B |
| 26 | CI | The Cigna Group | 76.88B | 1.39% | 385,696 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.61B | -1.72% | 275,104 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 66.56B | -1.15% | 5,612,694 | 20.61B |
| 29 | COR | Cencora, Inc. | 60.12B | 1.48% | 854,562 | 328.68B |
| 30 | ARGX | argenx SE | 56.71B | -1.13% | 155,477 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 55.87B | -0.49% | 1,298,879 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 54.16B | -0.79% | 1,960,125 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 52.94B | -1.24% | 2,241,295 | 28.34B |
| 34 | MDLN | Medline Inc. | 52.94B | -6.30% | 8,916,836 | 29.14B |
| 35 | HUM | Humana Inc. | 47.58B | 0.42% | 1,166,197 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.06B | -2.06% | 266,815 | 4.45B |
| 37 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.93B | -0.01% | 258,574 | 4.29B |
| 38 | HLN | Haleon plc | 42.83B | -0.71% | 3,688,858 | 14.85B |
| 39 | BDX | Becton, Dickinson and Company | 41.82B | -2.89% | 927,905 | 22.23B |
| 40 | RVMD | Revolution Medicines, Inc. | 40.04B | -1.12% | 593,322 | - |
| 41 | NTRA | Natera, Inc. | 39.07B | -3.01% | 633,859 | 2.50B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 38.47B | -4.65% | 3,244,540 | 17.35B |
| 43 | A | Agilent Technologies, Inc. | 36.38B | -1.77% | 734,992 | 7.23B |
| 44 | WAT | Waters Corporation | 36.29B | -1.42% | 362,176 | 3.77B |
| 45 | IQV | IQVIA Holdings Inc. | 33.76B | -2.86% | 360,319 | 16.63B |
| 46 | RPRX | Royalty Pharma plc | 33.61B | 1.18% | 1,510,219 | 2.44B |
| 47 | ONC | BeOne Medicines AG | 33.32B | -3.00% | 184,278 | 5.74B |
| 48 | CNC | Centene Corporation | 33.13B | 1.47% | 4,097,522 | 178.33B |
| 49 | ALC | Alcon Inc. | 32.52B | 0.06% | 1,713,594 | 10.63B |
| 50 | ZTS | Zoetis Inc. | 31.69B | -0.92% | 2,322,337 | 9.53B |
| 51 | VEEV | Veeva Systems Inc. | 30.64B | -1.91% | 748,562 | 3.32B |
| 52 | RMD | ResMed Inc. | 30.11B | -5.02% | 792,375 | 5.54B |
| 53 | BIIB | Biogen Inc. | 29.84B | -1.74% | 817,002 | 9.94B |
| 54 | MRNA | Moderna, Inc. | 29.54B | -6.66% | 4,099,997 | 2.23B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 29.51B | -0.03% | 1,601,553 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 28.42B | -2.06% | 2,635,100 | 4.39B |
| 57 | DXCM | DexCom, Inc. | 28.23B | -0.56% | 1,805,709 | 4.82B |
| 58 | PHG | Koninklijke Philips N.V. | 26.15B | -2.34% | 460,380 | 20.34B |
| 59 | ROIV | Roivant Sciences Ltd. | 25.96B | -0.61% | 4,266,797 | 8.26M |
| 60 | MTD | Mettler-Toledo International Inc. | 25.28B | -3.43% | 69,201 | 4.09B |
| 61 | INSM | Insmed Incorporated | 25.26B | 2.08% | 1,318,726 | 819.56M |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.89B | -1.07% | 320,820 | 3.22B |
| 63 | BNTX | BioNTech SE | 23.43B | -1.73% | 308,846 | 3.23B |
| 64 | UTHR | United Therapeutics Corporation | 23.39B | -2.26% | 106,468 | 3.17B |
| 65 | INCY | Incyte Corporation | 23.33B | -1.07% | 675,184 | 5.36B |
| 66 | DGX | Quest Diagnostics Incorporated | 23.04B | -1.59% | 242,829 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.82B | -1.97% | 198,779 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 20.85B | -3.48% | 1,343,636 | 1.08B |
| 69 | STE | STERIS plc | 20.42B | -2.74% | 592,050 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.23B | -2.62% | 3,268,604 | 14.56B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 17.78B | -0.38% | 456,869 | 3.10B |
| 72 | THC | Tenet Healthcare Corporation | 17.77B | -1.23% | 745,065 | 21.46B |
| 73 | GMAB | Genmab A/S | 17.71B | - | 1,826,586 | 3.90B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 17.08B | -1.26% | 357,871 | 8.41B |
| 75 | ASND | Ascendis Pharma A/S | 16.98B | 2.40% | 229,452 | 998.25M |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.44B | -0.81% | 297,615 | 4.44B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.12B | -1.02% | 730,886 | 579.96M |
| 78 | MEDP | Medpace Holdings, Inc. | 15.08B | -3.33% | 195,703 | 2.68B |
| 79 | DVA | DaVita Inc. | 14.81B | -1.28% | 299,477 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.72B | 0.67% | 809,644 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.10B | -1.70% | 1,777,375 | 2.38B |
| 82 | IONS | Ionis Pharmaceuticals, Inc. | 13.96B | -2.18% | 756,270 | 1.06B |
| 83 | COO | The Cooper Companies, Inc. | 13.69B | -2.36% | 1,044,247 | 4.23B |
| 84 | SOLV | Solventum Corporation | 13.02B | -0.07% | 351,448 | 8.26B |
| 85 | FMS | Fresenius Medical Care AG | 12.86B | -1.07% | 449,181 | 22.32B |
| 86 | AXSM | Axsome Therapeutics, Inc. | 12.75B | -0.79% | 271,255 | 708.24M |
| 87 | SNN | Smith & Nephew plc | 12.69B | -1.74% | 983,273 | 6.16B |
| 88 | ALGN | Align Technology, Inc. | 12.60B | -4.98% | 362,795 | 4.10B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.60B | 0.21% | 113,967 | 1.13B |
| 90 | ICLR | ICON Public Limited Company | 12.59B | -2.60% | 329,804 | 8.27B |
| 91 | PEN | Penumbra, Inc. | 12.51B | -0.07% | 113,096 | 1.45B |
| 92 | RVTY | Revvity, Inc. | 12.20B | -2.89% | 414,390 | 2.90B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.18B | -1.01% | 2,324,485 | 4.89B |
| 94 | SMMT | Summit Therapeutics Inc. | 12.12B | -1.67% | 1,046,025 | - |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.06B | -1.59% | 617,154 | 622.01M |
| 96 | MOH | Molina Healthcare, Inc. | 12.03B | 1.44% | 478,441 | 43.10B |
| 97 | ABVX | ABIVAX Société Anonyme | 12.00B | -2.15% | 773,242 | 5.67M |
| 98 | RDY | Dr. Reddy's Laboratories Limited | 11.73B | -1.20% | 828,357 | 3.58B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.58B | -0.72% | 574,643 | 3.24B |
| 100 | BAX | Baxter International Inc. | 11.40B | -3.43% | 2,310,482 | 11.32B |
| 101 | CYTK | Cytokinetics, Incorporated | 11.29B | -2.78% | 984,159 | 105.82M |
| 102 | PODD | Insulet Corporation | 11.03B | -1.46% | 367,715 | 2.90B |
| 103 | TECH | Bio-Techne Corporation | 10.99B | -0.08% | 3,515,115 | 1.21B |
| 104 | KRYS | Krystal Biotech, Inc. | 10.90B | 0.29% | 92,269 | 417.30M |
| 105 | EHC | Encompass Health Corporation | 10.88B | -0.93% | 435,155 | 6.07B |
| 106 | CRL | Charles River Laboratories International, Inc. | 10.79B | -2.06% | 740,833 | 4.03B |
| 107 | GMED | Globus Medical, Inc. | 10.34B | -3.35% | 991,393 | 3.10B |
| 108 | TEM | Tempus AI, Inc. | 10.16B | -5.87% | 3,084,785 | 1.36B |
| 109 | APGE | Apogee Therapeutics, Inc. | 10.00B | -0.04% | 810,481 | - |
| 110 | CORT | Corcept Therapeutics Incorporated | 9.98B | -1.17% | 1,036,995 | 769.10M |
| 111 | ENSG | The Ensign Group, Inc. | 9.91B | 0.07% | 179,460 | 5.27B |
| 112 | NUVL | Nuvalent, Inc. | 9.82B | 0.04% | 413,278 | - |
| 113 | HSIC | Henry Schein, Inc. | 9.48B | -4.17% | 1,374,313 | 13.38B |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.39B | -4.26% | 787,845 | 51.48M |
| 115 | UHS | Universal Health Services, Inc. | 9.37B | -4.04% | 526,744 | 17.76B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 9.35B | -3.33% | 869,987 | 1.51B |
| 117 | OSCR | Oscar Health, Inc. | 9.32B | -0.51% | 1,608,854 | 13.30B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.20B | 1.88% | 296,838 | 7.46M |
| 119 | IBRX | ImmunityBio, Inc. | 9.10B | -0.86% | 6,457,763 | 140.98M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.01B | -2.80% | 196,048 | 74.06M |
| 121 | ALKS | Alkermes plc | 8.98B | -2.39% | 548,956 | 1.56B |
| 122 | GKOS | Glaukos Corporation | 8.97B | 1.48% | 494,435 | 551.35M |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.80B | -0.04% | 10,556,084 | 18.07M |
| 124 | BRKR | Bruker Corporation | 8.60B | -2.96% | 918,902 | 3.46B |
| 125 | PCVX | Vaxcyte, Inc. | 8.31B | -5.11% | 549,346 | - |
| 126 | HIMS | Hims & Hers Health, Inc. | 8.27B | -1.23% | 7,595,805 | 2.37B |
| 127 | IMVT | Immunovant, Inc. | 8.07B | -1.90% | 429,171 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 8.03B | -2.35% | 946,836 | 700.35M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.00B | -2.23% | 362,218 | - |
| 130 | HQY | HealthEquity, Inc. | 7.97B | -1.64% | 313,702 | 1.34B |
| 131 | ATR | AptarGroup, Inc. | 7.94B | -2.58% | 123,296 | 3.87B |
| 132 | QGEN | Qiagen N.V. | 7.86B | -1.86% | 2,449,046 | 2.10B |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.84B | 0.20% | 823,103 | 569.61M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.76B | -1.12% | 261,310 | 217.17M |
| 135 | RGEN | Repligen Corporation | 7.75B | -1.73% | 689,022 | 763.34M |
| 136 | BIO | Bio-Rad Laboratories, Inc. | 7.60B | -2.95% | 241,183 | 2.59B |
| 137 | PTCT | PTC Therapeutics, Inc. | 7.34B | -0.75% | 404,795 | 827.11M |
| 138 | LQDA | Liquidia Corporation | 7.16B | -0.92% | 540,886 | 288.07M |
| 139 | PACS | PACS Group, Inc. | 7.05B | 2.12% | 339,279 | 5.43B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.91B | 2.59% | 197,781 | 1.55B |
| 141 | HNGE | Hinge Health, Inc. | 6.85B | -0.90% | 1,775,241 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.83B | -0.10% | 3,639,072 | - |
| 143 | AVTR | Avantor, Inc. | 6.74B | -3.19% | 2,578,040 | 6.55B |
| 144 | SRRK | Scholar Rock Holding Corporation | 6.63B | -2.16% | 332,757 | - |
| 145 | CHE | Chemed Corporation | 6.36B | -0.82% | 43,838 | 2.54B |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 6.28B | 2.45% | 1,374,296 | 7.50M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.24B | -1.32% | 160,199 | 274.48M |
| 148 | GRFS | Grifols, S.A. | 6.19B | 1.39% | 423,652 | 8.58B |
| 149 | CGON | CG Oncology, Inc. | 6.12B | 0.33% | 451,926 | 5.07M |
| 150 | DFTX | Definium Therapeutics, Inc. | 6.02B | 1.89% | 2,615,863 | - |
| 151 | BLCO | Bausch + Lomb Corporation | 5.92B | -2.87% | 142,574 | 5.21B |
| 152 | BLTE | Belite Bio, Inc | 5.90B | -4.81% | 97,288 | - |
| 153 | ERAS | Erasca, Inc. | 5.87B | 0.33% | 3,314,765 | - |
| 154 | TFX | Teleflex Incorporated | 5.77B | -1.64% | 87,460 | 2.13B |
| 155 | CRSP | CRISPR Therapeutics AG | 5.71B | -2.58% | 1,219,864 | 4.10M |
| 156 | BLLN | BillionToOne, Inc. | 5.55B | 2.17% | 630,300 | 354.54M |
| 157 | TWST | Twist Bioscience Corporation | 5.54B | -2.22% | 781,676 | 409.48M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.34B | -1.91% | 599,543 | 3.05B |
| 159 | CELC | Celcuity Inc. | 5.31B | -4.60% | 599,691 | - |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.31B | -1.30% | 683,304 | 536.20M |
| 161 | LEGN | Legend Biotech Corporation | 5.30B | -0.96% | 552,163 | 1.14B |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 5.20B | -0.73% | 312,383 | 1.34M |
| 163 | STVN | Stevanato Group S.p.A. | 5.17B | -3.27% | 96,060 | 1.39B |
| 164 | RDNT | RadNet, Inc. | 5.17B | -3.08% | 194,451 | 2.14B |
| 165 | SHC | Sotera Health Company | 5.04B | -1.91% | 1,323,371 | 1.19B |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 4.99B | -1.21% | 441,746 | 1.29B |
| 167 | ORKA | Oruka Therapeutics, Inc. | 4.96B | -2.60% | 515,577 | - |
| 168 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.95B | -4.31% | 419,138 | 754.05M |
| 169 | MANE | Veradermics, Incorporated | 4.94B | 1.24% | 350,350 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.90B | 5.50% | 908,345 | - |
| 171 | ALHC | Alignment Healthcare, Inc. | 4.89B | -1.58% | 1,843,533 | 4.26B |
| 172 | CAI | Caris Life Sciences, Inc. | 4.89B | -1.00% | 2,817,197 | 907.29M |
| 173 | TXG | 10x Genomics, Inc. | 4.76B | -0.95% | 3,099,420 | 638.78M |
| 174 | LIVN | LivaNova PLC | 4.60B | 0.21% | 313,168 | 1.43B |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.58B | -6.42% | 1,652,322 | - |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | -0.76% | 1,526,070 | 1.10B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.43B | 0.23% | 2,020,159 | 56.99M |
| 178 | VCYT | Veracyte, Inc. | 4.41B | -1.49% | 607,297 | 541.74M |
| 179 | WAY | Waystar Holding Corp. | 4.37B | -4.35% | 728,412 | 1.16B |
| 180 | MMSI | Merit Medical Systems, Inc. | 4.28B | -0.57% | 234,981 | 1.54B |
| 181 | MMED | MiniMed Group, Inc. | 4.22B | -2.28% | 1,055,689 | 3.10B |
| 182 | NVST | Envista Holdings Corporation | 4.19B | -5.11% | 1,439,249 | 2.81B |
| 183 | DNLI | Denali Therapeutics Inc. | 4.18B | 0.19% | 543,435 | - |
| 184 | LFST | LifeStance Health Group, Inc. | 4.13B | -2.20% | 2,117,931 | 1.49B |
| 185 | NAMS | NewAmsterdam Pharma Company N.V. | 4.13B | -4.49% | 281,995 | 22.57M |
| 186 | RLAY | Relay Therapeutics, Inc. | 4.10B | -4.61% | 1,698,280 | 10.68M |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.10B | -0.28% | 236,286 | 787.85M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 4.03B | -0.51% | 320,707 | 2.23B |
| 189 | DOCS | Doximity, Inc. | 4.00B | -3.87% | 1,093,423 | 644.86M |
| 190 | DYN | Dyne Therapeutics, Inc. | 3.94B | - | 2,528,243 | - |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.93B | 1.58% | 399,163 | - |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.89B | -2.73% | 115,227 | 803.79M |
| 193 | GPCR | Structure Therapeutics Inc. | 3.88B | -3.65% | 312,862 | - |
| 194 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.02% | 311,568 | 596.96M |
| 195 | ICUI | ICU Medical, Inc. | 3.81B | -1.80% | 83,474 | 2.16B |
| 196 | ALMS | Alumis Inc. | 3.79B | 1.61% | 2,712,799 | 8.40M |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.75B | -1.55% | 309,580 | 236.00M |
| 198 | BEAM | Beam Therapeutics Inc. | 3.66B | -2.99% | 2,832,140 | 164.01M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.60B | -6.64% | 648,864 | 225.27M |
| 200 | BKD | Brookdale Senior Living Inc. | 3.58B | -2.66% | 5,832,561 | 3.00B |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.55B | -3.46% | 463,850 | - |
| 202 | OGN | Organon & Co. | 3.54B | -0.11% | 994,492 | 6.16B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.50B | 1.15% | 754,082 | 415.62M |
| 204 | PRVA | Privia Health Group, Inc. | 3.45B | 0.55% | 397,725 | 2.25B |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.42B | 15.97% | 1,178,094 | - |
| 206 | RARE | Ultragenyx Pharmaceutical Inc. | 3.40B | -3.35% | 2,771,572 | 670.00M |
| 207 | OPCH | Option Care Health, Inc. | 3.39B | 0.07% | 717,255 | 5.67B |
| 208 | HAE | Haemonetics Corporation | 3.38B | -0.57% | 244,787 | 1.33B |
| 209 | NHC | National HealthCare Corporation | 3.35B | -0.88% | 40,226 | 1.53B |
| 210 | WRBY | Warby Parker Inc. | 3.33B | -3.21% | 1,139,727 | 890.57M |
| 211 | ADPT | Adaptive Biotechnologies Corporation | 3.18B | -4.66% | 979,724 | 295.41M |
| 212 | ITGR | Integer Holdings Corporation | 3.13B | 0.26% | 259,550 | 1.86B |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.08B | -1.68% | 751,938 | 865.00K |
| 214 | TARS | Tarsus Pharmaceuticals, Inc. | 3.01B | -0.91% | 279,332 | 535.08M |
| 215 | IRON | Disc Medicine, Inc. | 3.00B | -1.55% | 220,006 | - |
| 216 | VERA | Vera Therapeutics, Inc. | 2.98B | -3.39% | 2,257,873 | - |
| 217 | MBX | MBX Biosciences, Inc. | 2.94B | -0.42% | 1,469,433 | - |
| 218 | GRAL | GRAIL, Inc. | 2.92B | -1.19% | 333,836 | 156.12M |
| 219 | QURE | uniQure N.V. | 2.90B | 2.03% | 661,554 | 18.09M |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.83B | -3.67% | 522,147 | 3.37B |
| 221 | KLRA | Kailera Therapeutics, Inc. | 2.82B | -2.16% | 812,818 | - |
| 222 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.80B | 0.32% | 3,826,119 | 885.72M |
| 223 | SUPN | Supernus Pharmaceuticals, Inc. | 2.78B | 0.06% | 408,276 | 776.83M |
| 224 | IMNM | Immunome, Inc. | 2.75B | -0.37% | 755,024 | 4.02M |
| 225 | MLYS | Mineralys Therapeutics, Inc. | 2.62B | -2.25% | 575,813 | - |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.60B | -6.21% | 1,265,266 | - |
| 227 | AGIO | Agios Pharmaceuticals, Inc. | 2.58B | -1.50% | 648,565 | 66.05M |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.56B | 1.05% | 561,480 | 1.46B |
| 229 | ESTA | Establishment Labs Holdings Inc. | 2.56B | -4.63% | 292,997 | 229.58M |
| 230 | BHVN | Biohaven Ltd. | 2.51B | 7.01% | 3,804,521 | - |
| 231 | NKTR | Nektar Therapeutics | 2.48B | -2.14% | 326,752 | 55.63M |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.46B | -2.40% | 486,892 | 71.78M |
| 233 | CLOV | Clover Health Investments, Corp. | 2.45B | -6.80% | 7,266,683 | 2.21B |
| 234 | PHVS | Pharvaris N.V. | 2.44B | 1.10% | 458,541 | - |
| 235 | TMDX | TransMedics Group, Inc. | 2.43B | -0.95% | 858,862 | 635.89M |
| 236 | KOD | Kodiak Sciences Inc. | 2.43B | 1.61% | 367,980 | - |
| 237 | PGNY | Progyny, Inc. | 2.43B | 0.70% | 580,808 | 1.29B |
| 238 | SLS | SELLAS Life Sciences Group, Inc. | 2.42B | -8.85% | 10,750,188 | - |
| 239 | VCEL | Vericel Corporation | 2.40B | 0.15% | 704,792 | 292.09M |
| 240 | XRAY | DENTSPLY SIRONA Inc. | 2.35B | -3.65% | 2,086,036 | 3.68B |
| 241 | ASTH | Astrana Health, Inc. | 2.34B | 0.20% | 131,771 | 3.53B |
| 242 | LMAT | LeMaitre Vascular, Inc. | 2.33B | -2.17% | 116,433 | 256.28M |
| 243 | NTLA | Intellia Therapeutics, Inc. | 2.32B | -4.93% | 1,863,080 | 66.09M |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.31B | -3.10% | 142,477 | 1.09B |
| 245 | AXGN | Axogen, Inc. | 2.27B | -4.08% | 1,052,144 | 238.11M |
| 246 | HTFL | HeartFlow, Inc. | 2.26B | -4.18% | 1,280,738 | 191.42M |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.25B | -3.39% | 1,536,857 | 52.04M |
| 248 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | -1.06% | 334,206 | 899.11M |
| 249 | SNDX | Syndax Pharmaceuticals, Inc. | 2.18B | 5.64% | 1,284,117 | 217.17M |
| 250 | ZLAB | Zai Lab Limited | 2.17B | -0.16% | 943,803 | 453.28M |
| 251 | ABCL | AbCellera Biologics Inc. | 2.17B | -7.67% | 9,369,295 | 79.21M |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.16B | -4.45% | 684,904 | 70.92M |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.15B | -0.22% | 865,722 | 1.93B |
| 254 | SGRY | Surgery Partners, Inc. | 2.14B | -3.90% | 1,315,385 | 3.34B |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | 2.12% | 3,185,872 | 2.18B |
| 256 | ADMA | ADMA Biologics, Inc. | 2.12B | -0.54% | 2,278,218 | 509.86M |
| 257 | AVAH | Aveanna Healthcare Holdings Inc. | 2.09B | -0.10% | 2,987,699 | 2.52B |
| 258 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.73% | 663,103 | 298.30M |
| 259 | TSHA | Taysha Gene Therapies, Inc. | 2.08B | -0.15% | 2,606,411 | 7.47M |
| 260 | OMCL | Omnicell, Inc. | 2.05B | 1.71% | 746,704 | 1.23B |
| 261 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -1.87% | 57,172 | - |
| 262 | NVCR | NovoCure Limited | 2.04B | -0.48% | 399,944 | 674.41M |
| 263 | GENB | Generate Biomedicines, Inc. | 2.03B | -2.16% | 804,167 | 30.30M |
| 264 | LKFT | Lakefront Biotherapeutics NV | 2.01B | 0.75% | 98,746 | 1.20B |
| 265 | NEOG | Neogen Corporation | 2.01B | -1.65% | 460,705 | 870.56M |
| 266 | GLUE | Monte Rosa Therapeutics, Inc. | 2.00B | -3.16% | 582,377 | 42.95M |
| 267 | STOK | Stoke Therapeutics, Inc. | 1.99B | -3.00% | 201,152 | 32.08M |
| 268 | SION | Sionna Therapeutics, Inc. | 1.99B | -2.03% | 266,004 | - |
| 269 | KARD | Kardigan, Inc. | 1.99B | -6.76% | 652,955 | - |
| 270 | UFPT | UFP Technologies, Inc. | 1.97B | -3.39% | 146,154 | 608.85M |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.96B | -2.97% | 290,580 | -665.00K |
| 272 | HCM | HUTCHMED (China) Limited | 1.96B | 0.99% | 11,711 | 548.51M |
| 273 | NUVB | Nuvation Bio Inc. | 1.95B | -1.06% | 4,941,609 | 143.05M |
| 274 | WGS | GeneDx Holdings Corp. | 1.95B | 0.31% | 551,795 | 442.68M |
| 275 | PLSE | Pulse Biosciences, Inc. | 1.95B | 0.29% | 221,390 | 751.00K |
| 276 | RXRX | Recursion Pharmaceuticals, Inc. | 1.95B | -4.56% | 15,617,822 | 66.41M |
| 277 | ADUS | Addus HomeCare Corporation | 1.94B | 0.33% | 287,373 | 1.45B |
| 278 | PGEN | Precigen, Inc. | 1.94B | -1.18% | 1,586,701 | 31.60M |
| 279 | ANAB | AnaptysBio, Inc. | 1.93B | -1.96% | 251,968 | 232.39M |
| 280 | TYRA | Tyra Biosciences, Inc. | 1.93B | 1.85% | 602,280 | - |
| 281 | RAPP | Rapport Therapeutics, Inc. | 1.93B | 1.83% | 154,070 | 20.00M |
| 282 | NBTX | Nanobiotix S.A. | 1.93B | -0.13% | 35,998 | 38.27M |
| 283 | IOVA | Iovance Biotherapeutics, Inc. | 1.91B | -1.72% | 6,873,358 | 285.61M |
| 284 | ATAI | AtaiBeckley Inc. | 1.91B | -0.19% | 7,806,443 | 3.49M |
| 285 | BCAX | Bicara Therapeutics Inc. | 1.90B | -4.64% | 867,122 | - |
| 286 | BFLY | Butterfly Network, Inc. | 1.90B | -4.09% | 3,415,467 | 102.92M |
| 287 | AGL | agilon health, inc. | 1.88B | 4.83% | 245,486 | 5.82B |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.87B | -2.25% | 137,987 | 367.34M |
| 289 | ZYME | Zymeworks Inc. | 1.86B | -2.69% | 197,571 | 81.26M |
| 290 | NEO | NeoGenomics, Inc. | 1.85B | -1.79% | 2,815,740 | 745.97M |
| 291 | GHRS | GH Research PLC | 1.84B | -0.15% | 186,104 | - |
| 292 | BHC | Bausch Health Companies Inc. | 1.83B | -0.41% | 506,838 | 10.53B |
| 293 | ZBIO | Zenas BioPharma, Inc. | 1.82B | 3.92% | 795,208 | 10.00M |
| 294 | URGN | UroGen Pharma Ltd. | 1.81B | -1.39% | 246,924 | 140.49M |
| 295 | MESO | Mesoblast Limited | 1.81B | -3.22% | 70,131 | 65.38M |
| 296 | ANIP | ANI Pharmaceuticals, Inc. | 1.80B | -1.42% | 228,491 | 923.71M |
| 297 | ABSI | Absci Corporation | 1.77B | -7.68% | 3,295,371 | 1.84M |
| 298 | CMPS | COMPASS Pathways plc | 1.77B | 0.73% | 3,558,053 | - |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.76B | -3.26% | 468,166 | 20.00M |
| 300 | ALMR | Alamar Biosciences, Inc. | 1.75B | 0.28% | 165,636 | 87.16M |
| 301 | MPLT | MapLight Therapeutics, Inc. | 1.75B | 3.97% | 373,881 | - |
| 302 | VIR | Vir Biotechnology, Inc. | 1.72B | -0.63% | 519,920 | 65.50M |
| 303 | TRLV | Trulieve Cannabis Corp. | 1.71B | -0.45% | 862,558 | 1.17B |
| 304 | ATRC | AtriCure, Inc. | 1.71B | 2.90% | 239,491 | 552.16M |
| 305 | DMRA | Damora Therapeutics, Inc. | 1.69B | -8.23% | 678,855 | - |
| 306 | IMCR | Immunocore Holdings plc | 1.69B | -0.63% | 190,148 | 412.81M |
| 307 | HROW | Harrow, Inc. | 1.67B | -2.82% | 261,456 | 268.68M |
| 308 | INVA | Innoviva, Inc. | 1.66B | 1.30% | 206,309 | 420.69M |
| 309 | SEPN | Septerna, Inc. | 1.65B | 2.12% | 287,730 | 72.26M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.64B | -1.68% | 243,897 | 1.85B |
| 311 | TDOC | Teladoc Health, Inc. | 1.64B | -4.73% | 3,422,476 | 2.51B |
| 312 | AAPG | Ascentage Pharma Group International | 1.63B | 0.96% | 7,625 | 82.08M |
| 313 | FTRE | Fortrea Holdings Inc. | 1.60B | -3.40% | 395,329 | 2.71B |
| 314 | AKTS | Aktis Oncology, Inc. | 1.59B | 4.02% | 711,739 | 8.28M |
| 315 | COAG | Hemab Therapeutics Holdings, Inc. | 1.58B | 7.62% | 347,135 | - |
| 316 | SVRA | Savara Inc. | 1.58B | 0.32% | 543,606 | - |
| 317 | KMTS | Kestra Medical Technologies, Ltd. | 1.57B | -3.30% | 139,358 | 83.72M |
| 318 | INNV | InnovAge Holding Corp. | 1.56B | -1.12% | 296,620 | 949.17M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.55B | -1.72% | 419,325 | - |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.54B | -3.22% | 424,475 | - |
| 321 | NVAX | Novavax, Inc. | 1.54B | -1.16% | 3,780,148 | 596.34M |
| 322 | ARDT | Ardent Health, Inc. | 1.49B | -3.88% | 232,166 | 6.43B |
| 323 | XERS | Xeris Biopharma Holdings, Inc. | 1.48B | -3.86% | 1,506,847 | 314.85M |
| 324 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.48B | -3.46% | 750,035 | 204.73M |
| 325 | PRGO | Perrigo Company plc | 1.47B | -4.92% | 865,416 | 4.18B |
| 326 | INBX | Inhibrx Biosciences, Inc. | 1.42B | -4.03% | 230,665 | 1.30M |
| 327 | CDNA | CareDx, Inc. | 1.42B | -2.86% | 644,118 | 412.82M |
| 328 | INSP | Inspire Medical Systems, Inc. | 1.42B | -1.56% | 1,253,658 | 915.25M |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.42B | -1.12% | 1,340,128 | 787.08M |
| 330 | STAA | STAAR Surgical Company | 1.40B | 6.03% | 1,427,345 | 290.38M |
| 331 | PSNL | Personalis, Inc. | 1.40B | -4.65% | 1,982,100 | 64.52M |
| 332 | ENOV | Enovis Corporation | 1.38B | -6.35% | 358,237 | 2.28B |
| 333 | OMDA | Omada Health, Inc. | 1.37B | -0.09% | 1,251,380 | 283.30M |
| 334 | AHG | Akso Health Group | 1.36B | 1.96% | 5,203 | 14.84M |
| 335 | IART | Integra LifeSciences Holdings Corporation | 1.36B | 0.20% | 234,989 | 1.64B |
| 336 | PNTG | The Pennant Group, Inc. | 1.36B | -1.50% | 122,493 | 1.02B |
| 337 | IMTX | Immatics N.V. | 1.35B | -3.46% | 252,800 | 43.00M |
| 338 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | 2.88% | 2,610,001 | - |
| 339 | JBIO | Jade Biosciences, Inc. | 1.34B | 0.36% | 857,284 | - |
| 340 | AHCO | AdaptHealth Corp. | 1.33B | -1.28% | 369,319 | 3.29B |
| 341 | BLFS | BioLife Solutions, Inc. | 1.33B | -2.69% | 222,608 | 101.66M |
| 342 | ARDX | Ardelyx, Inc. | 1.33B | -0.28% | 1,290,439 | 427.68M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.32B | -1.81% | 83,651 | 1.50B |
| 344 | MNKD | MannKind Corporation | 1.31B | 0.59% | 1,959,492 | 360.78M |
| 345 | MGTX | MeiraGTx Holdings plc | 1.31B | -3.55% | 804,818 | 79.76M |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.30B | 0.99% | 371,510 | 3.42B |
| 347 | CAPR | Capricor Therapeutics, Inc. | 1.29B | 0.14% | 1,456,079 | 11.13M |
| 348 | AVLN | Avalyn Pharma Inc. | 1.28B | 1.83% | 419,968 | - |
| 349 | IRMD | IRADIMED CORPORATION | 1.25B | -2.60% | 161,328 | 86.28M |
| 350 | WVE | Wave Life Sciences Ltd. | 1.21B | -1.80% | 969,791 | 71.80M |
| 351 | ALVO | Alvotech | 1.20B | -3.30% | 181,106 | 562.04M |
| 352 | NUTX | Nutex Health Inc. | 1.20B | -6.87% | 97,277 | 879.95M |
| 353 | SANA | Sana Biotechnology, Inc. | 1.19B | -3.40% | 3,369,588 | - |
| 354 | SDGR | Schrödinger, Inc. | 1.19B | -3.58% | 556,738 | 254.91M |
| 355 | AORT | Artivion, Inc. | 1.18B | -0.74% | 151,953 | 458.69M |
| 356 | EYPT | EyePoint, Inc. | 1.17B | -0.07% | 1,897,267 | 7.61M |
| 357 | XNCR | Xencor, Inc. | 1.17B | 0.96% | 307,919 | 97.36M |
| 358 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | -1.06% | 394,202 | 1.03B |
| 359 | COLL | Collegium Pharmaceutical, Inc. | 1.17B | -1.15% | 125,307 | 796.33M |
| 360 | AVNS | Avanos Medical, Inc. | 1.17B | 0.02% | 413,051 | 715.90M |
| 361 | DRTS | Alpha Tau Medical Ltd. | 1.15B | -0.27% | 317,905 | - |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | -4.66% | 678,862 | 322.02M |
| 363 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 16.62% | 223,376 | - |
| 364 | AZTA | Azenta, Inc. | 1.13B | -3.39% | 534,154 | 596.48M |
| 365 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | -1.21% | 251,873 | - |
| 366 | VOR | Vor Biopharma Inc. | 1.10B | 1.04% | 2,135,349 | - |
| 367 | QDEL | QuidelOrtho Corporation | 1.09B | -6.13% | 881,320 | 2.66B |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -3.81% | 708,371 | - |
| 369 | OPK | OPKO Health, Inc. | 1.08B | -4.03% | 1,186,067 | 581.12M |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.08B | -1.20% | 54,157 | 787.69M |
| 371 | KURA | Kura Oncology, Inc. | 1.08B | 1.08% | 1,916,981 | 71.64M |
| 372 | SLDB | Solid Biosciences Inc. | 1.06B | -3.14% | 697,009 | - |
| 373 | CERT | Certara, Inc. | 1.05B | -6.00% | 1,124,493 | 419.75M |
| 374 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -5.46% | 795,262 | - |
| 375 | TNDM | Tandem Diabetes Care, Inc. | 1.04B | -1.75% | 1,870,774 | 1.03B |
| 376 | BIOA | BioAge Labs, Inc. | 1.04B | -4.45% | 284,150 | 10.32M |
| 377 | CRON | Cronos Group Inc. | 1.03B | -0.55% | 323,726 | 159.54M |
| 378 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.48% | 1,222,432 | 191.45M |
| 379 | CNMD | CONMED Corporation | 1.02B | -0.91% | 158,274 | 1.37B |
| 380 | JANX | Janux Therapeutics, Inc. | 1.02B | 3.16% | 1,364,554 | 13.73M |
| 381 | IVA | Inventiva S.A. | 1.01B | -5.59% | 1,867,338 | 7.94M |
| 382 | PHAR | Pharming Group N.V. | 1.01B | -1.11% | 6,273 | 369.49M |
| 383 | BVS | Bioventus Inc. | 1.01B | 5.40% | 860,426 | 576.30M |
| 384 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -0.21% | 1,296,627 | 59.00K |
| 385 | ETON | Eton Pharmaceuticals, Inc. | 1.00B | -2.85% | 178,703 | 86.93M |
| 386 | PCRX | Pacira BioSciences, Inc. | 1.00B | -1.16% | 324,357 | 734.86M |
| 387 | GERN | Geron Corporation | 1.00B | 2.35% | 5,930,180 | 196.12M |
| 388 | GDRX | GoodRx Holdings, Inc. | 999.09M | -2.64% | 304,431 | 787.89M |
| 389 | EVO | Evotec SE | 991.39M | -3.63% | 13,112 | 859.03M |
| 390 | LXRX | Lexicon Pharmaceuticals, Inc. | 986.12M | -6.33% | 1,482,403 | 69.64M |
| 391 | LBRX | LB Pharmaceuticals Inc | 979.88M | -0.35% | 305,712 | - |
| 392 | GLAS | Glass House Brands Inc. | 977.51M | -0.61% | 359,475 | 177.68M |
| 393 | ANNX | Annexon, Inc. | 977.32M | -7.23% | 5,274,797 | - |
| 394 | DBVT | DBV Technologies S.A. | 971.65M | -3.46% | 137,321 | 5.74M |
| 395 | DSGN | Design Therapeutics, Inc. | 954.34M | 3.87% | 1,036,385 | - |
| 396 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | 2.77% | 627,801 | 204.89M |
| 397 | AVR | Anteris Technologies Global Corp. | 937.89M | -2.87% | 1,042,517 | 1.85M |
| 398 | REPL | Replimune Group, Inc. | 916.68M | -5.13% | 1,505,050 | - |
| 399 | INMD | InMode Ltd. | 916.17M | -0.55% | 439,173 | 374.64M |
| 400 | ANRO | Alto Neuroscience, Inc. | 893.49M | -0.93% | 335,717 | - |
| 401 | TBPH | Theravance Biopharma, Inc. | 880.56M | -0.12% | 230,268 | 109.78M |
| 402 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 2,453,602 | 238.37M |
| 403 | TENX | Tenax Therapeutics, Inc. | 871.63M | -1.84% | 651,953 | - |
| 404 | GMRS | GMR Solutions Inc. | 841.50M | 5.70% | 666,196 | 5.83B |
| 405 | ZVRA | Zevra Therapeutics, Inc. | 839.81M | -1.62% | 435,040 | 122.29M |
| 406 | AMPH | Amphastar Pharmaceuticals, Inc. | 829.83M | -6.27% | 156,444 | 720.53M |
| 407 | HSTM | HealthStream, Inc. | 828.69M | -0.30% | 74,552 | 311.78M |
| 408 | ESPR | Esperion Therapeutics, Inc. | 822.04M | 0.16% | 20,017,769 | 418.24M |
| 409 | OCS | Oculis Holding AG | 820.07M | 0.15% | 198,897 | 1.40M |
| 410 | PRME | Prime Medicine, Inc. | 813.68M | 12.91% | 7,353,078 | 4.03M |
| 411 | CTMX | CytomX Therapeutics, Inc. | 802.24M | -4.04% | 828,071 | 35.54M |
| 412 | RIGL | Rigel Pharmaceuticals, Inc. | 794.11M | 0.85% | 306,754 | 299.77M |
| 413 | RGNX | REGENXBIO Inc. | 787.37M | 1.40% | 2,385,550 | 87.82M |
| 414 | IRWD | Ironwood Pharmaceuticals, Inc. | 785.21M | 6.71% | 4,970,951 | 361.51M |
| 415 | SPRY | ARS Pharmaceuticals, Inc. | 783.50M | -3.66% | 1,122,767 | 98.99M |
| 416 | AURA | Aura Biosciences, Inc. | 783.13M | 1.00% | 645,990 | - |
| 417 | IMMX | Immix Biopharma, Inc. | 783.09M | -8.49% | 2,428,192 | - |
| 418 | CLYM | Climb Bio, Inc. | 777.03M | 1.12% | 1,401,352 | - |
| 419 | ACRS | Aclaris Therapeutics, Inc. | 775.13M | -1.25% | 535,197 | 8.37M |
| 420 | SIBN | SI-BONE, Inc. | 761.03M | -0.81% | 922,405 | 206.22M |
| 421 | OMER | Omeros Corporation | 750.17M | 0.34% | 571,904 | 9.89M |
| 422 | ODTX | Odyssey Therapeutics, Inc. | 748.81M | -1.70% | 106,712 | 1.06M |
| 423 | CBLL | CeriBell, Inc. | 732.67M | -2.72% | 104,191 | 95.07M |
| 424 | ALLO | Allogene Therapeutics, Inc. | 731.73M | -1.40% | 12,389,497 | 22.00K |
| 425 | NGNE | Neurogene Inc. | 729.82M | -0.48% | 299,369 | 925.00K |
| 426 | BBNX | Beta Bionics, Inc. | 728.14M | -3.88% | 437,716 | 110.24M |
| 427 | TRAX | First Tracks Biotherapeutics, Inc. | 724.71M | 5.01% | 551,677 | - |
| 428 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 722.57M | 8.81% | 722,528 | - |
| 429 | FTH | Faeth Therapeutics, Inc. | 722.32M | 7.32% | 99,485 | - |
| 430 | SSII | SS Innovations International, Inc. | 720.47M | 0.56% | 85,822 | 48.47M |
| 431 | CSTL | Castle Biosciences, Inc. | 710.63M | -1.68% | 74,296 | 339.92M |
| 432 | CADL | Candel Therapeutics, Inc. | 707.42M | -1.98% | 890,654 | - |
| 433 | SLBT | SL Science Holding Limited | 701.45M | -2.69% | 71,804 | - |
| 434 | CRMD | CorMedix Inc. | 691.16M | -0.68% | 401,068 | 400.05M |
| 435 | SGP | SpyGlass Pharma, Inc. | 684.05M | 4.82% | 140,851 | - |
| 436 | TCMD | Tactile Systems Technology, Inc. | 683.68M | -3.75% | 67,197 | 343.52M |
| 437 | FDMT | 4D Molecular Therapeutics, Inc. | 680.64M | 1.56% | 757,145 | 88.24M |
| 438 | RLMD | Relmada Therapeutics, Inc. | 675.49M | 0.47% | 721,091 | - |
| 439 | TECX | Tectonic Therapeutic, Inc. | 669.76M | -2.85% | 118,886 | - |
| 440 | PHR | Phreesia, Inc. | 666.95M | -1.46% | 332,871 | 495.59M |
| 441 | MNPR | Monopar Therapeutics Inc. | 664.99M | 4.25% | 297,962 | - |
| 442 | DRUG | Bright Minds Biosciences Inc. | 640.14M | 0.93% | 147,069 | - |
| 443 | MDXG | MiMedx Group, Inc. | 638.98M | 2.14% | 578,215 | 389.42M |
| 444 | ACHV | Achieve Life Sciences, Inc. | 635.97M | -4.98% | 1,093,542 | - |
| 445 | AGMB | AgomAb Therapeutics NV | 627.42M | -4.07% | 45,474 | - |
| 446 | EVH | Evolent Health, Inc. | 622.58M | 1.00% | 625,591 | 1.89B |
| 447 | GYRE | Gyre Therapeutics, Inc. | 621.33M | -3.00% | 65,069 | 117.05M |
| 448 | CERS | Cerus Corporation | 619.14M | -4.04% | 959,040 | 216.56M |
| 449 | ALT | Altimmune, Inc. | 604.81M | 2.98% | 3,499,454 | 36.00K |
| 450 | BWAY | BrainsWay Ltd. | 604.29M | -0.13% | 73,128 | 56.22M |
| 451 | KYTX | Kyverna Therapeutics, Inc. | 597.01M | 1.45% | 659,299 | - |
| 452 | FLGT | Fulgent Genetics, Inc. | 592.72M | -0.71% | 100,083 | 320.35M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 585.10M | 7.49% | 596,004 | - |
| 454 | NVCT | Nuvectis Pharma, Inc. | 584.33M | -3.46% | 141,174 | - |
| 455 | EIKN | Eikon Therapeutics, Inc. | 580.37M | -7.59% | 527,941 | - |
| 456 | DNA | Ginkgo Bioworks Holdings, Inc. | 578.12M | -5.25% | 661,239 | 151.40M |
| 457 | NPCE | NeuroPace, Inc. | 574.82M | -5.28% | 40,329 | 99.53M |
| 458 | CTKB | Cytek Biosciences, Inc. | 573.39M | -2.63% | 272,914 | 204.17M |
| 459 | ASMB | Assembly Biosciences, Inc. | 569.35M | -0.81% | 135,958 | 71.10M |
| 460 | PROK | ProKidney Corp. | 567.87M | -3.59% | 409,278 | 889.00K |
| 461 | TOI | The Oncology Institute, Inc. | 564.90M | -2.59% | 2,157,012 | 545.76M |
| 462 | EDIT | Editas Medicine, Inc. | 563.20M | -2.13% | 2,454,160 | 38.69M |
| 463 | XOMA | XOMA Royalty Corporation | 562.97M | 2.28% | 86,880 | 48.56M |
| 464 | CBIO | Crescent Biopharma, Inc. | 560.91M | -0.88% | 177,156 | 11.88M |
| 465 | ARVN | Arvinas, Inc. | 550.37M | -0.70% | 245,841 | 89.40M |
| 466 | MYGN | Myriad Genetics, Inc. | 545.91M | -1.37% | 545,083 | 829.00M |
| 467 | CTEV | Claritev Corporation | 545.87M | 1.27% | 79,476 | 978.76M |
| 468 | WEAV | Weave Communications, Inc. | 537.07M | -0.59% | 524,481 | 248.72M |
| 469 | STRO | Sutro Biopharma, Inc. | 536.55M | 0.78% | 249,901 | 99.61M |
| 470 | ANGO | AngioDynamics, Inc. | 533.11M | -2.14% | 120,906 | 313.73M |
| 471 | AQST | Aquestive Therapeutics, Inc. | 531.91M | -2.08% | 512,766 | 50.27M |
| 472 | STTK | Shattuck Labs, Inc. | 527.56M | -5.23% | 1,033,360 | 1.00M |
| 473 | FBRX | Forte Biosciences, Inc. | 522.19M | -3.96% | 323,849 | - |
| 474 | ZURA | Zura Bio Limited | 521.54M | 8.07% | 1,174,194 | - |
| 475 | TLRY | Tilray Brands, Inc. | 521.27M | 1.39% | 2,628,359 | 858.28M |
| 476 | CLPT | ClearPoint Neuro, Inc. | 511.02M | -2.52% | 210,610 | 40.61M |
| 477 | KIDS | OrthoPediatrics Corp. | 509.59M | 0.10% | 69,307 | 243.30M |
| 478 | OVID | Ovid Therapeutics Inc. | 509.53M | -1.09% | 3,026,985 | 7.12M |
| 479 | RZLT | Rezolute, Inc. | 508.75M | -2.01% | 594,338 | - |
| 480 | PRTA | Prothena Corporation plc | 508.09M | 0.26% | 168,335 | 57.94M |
| 481 | PRLD | Prelude Therapeutics Incorporated | 507.79M | 3.02% | 272,468 | 16.72M |
| 482 | OCGN | Ocugen, Inc. | 507.78M | - | 7,553,879 | 4.47M |
| 483 | NRC | NRC Health | 504.82M | -1.62% | 24,554 | 138.64M |
| 484 | NNNN | Anbio Biotechnology | 504.31M | -1.79% | 37,302 | 8.65M |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 486 | VALN | Valneva SE | 493.63M | 0.76% | 8,898 | 180.25M |
| 487 | CABA | Cabaletta Bio, Inc. | 492.43M | -2.58% | 5,328,339 | - |
| 488 | CYH | Community Health Systems, Inc. | 483.57M | -6.54% | 1,973,594 | 12.29B |
| 489 | EVMN | Evommune, Inc. | 477.24M | -0.67% | 1,142,281 | 10.00M |
| 490 | OFIX | Orthofix Medical Inc. | 468.89M | -1.02% | 106,849 | 825.37M |
| 491 | VMD | Viemed Healthcare, Inc. | 466.56M | 0.83% | 159,408 | 286.57M |
| 492 | EOLS | Evolus, Inc. | 464.61M | 1.66% | 594,387 | 301.79M |
| 493 | PACB | Pacific Biosciences of California, Inc. | 464.35M | -4.17% | 2,201,627 | 160.03M |
| 494 | CCCC | C4 Therapeutics, Inc. | 463.28M | -3.68% | 6,695,984 | 34.86M |
| 495 | SOPH | SOPHiA GENETICS SA | 462.26M | 1.29% | 311,878 | 81.18M |
| 496 | VREX | Varex Imaging Corporation | 458.13M | 2.07% | 151,959 | 857.50M |
| 497 | MOBI | Mobia Medical, Inc. | 455.84M | 11.01% | 154,279 | 38.45M |
| 498 | AUTL | Autolus Therapeutics plc | 452.44M | 5.59% | 1,653,855 | 92.62M |
| 499 | RCKT | Rocket Pharmaceuticals, Inc. | 449.33M | 1.11% | 1,438,048 | - |
| 500 | DCTH | Delcath Systems, Inc. | 449.30M | -3.16% | 184,660 | 90.44M |